211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  1992-08-15

• Fields of study

  Medicine, Physics

• Identifiers
  PMID 1643635
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new radioactive drug selectively accumulating in melanoma cells

  2004cited by this paper
• 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases.

  1990cited by this paper
• Uptake and therapeutic effectiveness of 125I- and 211At-methylene blue for pigmented melanoma in an animal model system.

  1989cited by this paper
• Toxicity of Astatine-211 in the Mouse

  1988cited by this paper
• Potential diagnostic and therapeutic agents for malignant melanoma: Synthesis of heavy radiohalogenated derivatives of methylene blue by electrophilic and nucleophilic methods

  1986cited by this paper
• The radiation response of V79 and human tumour multicellular spheroids--cell survival and growth delay studies.

  1984cited by this paper
• In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice.

  1978cited by this paper
• Introduction to Medical Laboratory Technology

  1976cited by this paper
• THE REACTION OF UVEAL PIGMENT IN VITRO WITH POLYCYCLIC COMPOUNDS.

  1964cited by this paper
• A Quantitative Study of the Growth of the Walker Rat Tumor and the Flexner-Jobling Rat Carcinoma

  1935cited by this paper

• PET and SPECT imaging of melanoma: the state of the art

  2017cites this paper
• P2X7 receptor as a novel drug delivery system to increase the entrance of hydrophilic drugs into cells during photodynamic therapy

  2016cites this paper
• 211At labeling of a monoclonal antibody and its Fab fragment: Cytotoxicity on human gastric cancer cells and biodistribution in nude mice with tumor xenografts

  2014cites this paper
• Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand

  2014cites this paper
• Dye‐Enhanced Multimodal Confocal Imaging as a Novel Approach to Intraoperative Diagnosis of Brain Tumors

  2013cites this paper
• Synthesis and Radiosynthesis of a Novel PET Fluorobenzyl Piperazine for Melanoma Tumour Imaging; [18F]MEL054

  2013cites this paper
• Identifying brain neoplasms using dye-enhanced multimodal confocal imaging.

  2012cites this paper
• Astatine-211 labeling of protein using TCP as a bi-functional linker: synthesis and preliminary evaluation in vivo and in vitro

  2011cites this paper
• Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models.

  2010cites this paper
• MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy*

  2010cites this paper
• Delineating melanoma using multimodal polarized light imaging

  2009cites this paper
• Radioiodinated methylene blue--a promising agent for melanoma scintigraphy: labelling, stability and in vitro uptake by melanoma cells.

  2008cites this paper
• Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

  2008cites this paper
• Astatine-211 labeling of insulin: Synthesis and preliminary evaluation in vivo and in vitro

  2007cites this paper
• Small compounds for 'targeted radiotherapy

  2007cites this paper
• CANCER DRUG DISCOVERY AND DEVELOPMENT

  2007cites this paper
• Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.

  2007cites this paper
• Targeted α-Particle Therapy

  2005cites this paper
• Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

  2005cites this paper
• Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At.

  2001cites this paper
• Methylene blue inhibits polymerase 1 enzyme and sensitizes Escherichia coli bacteria to X-rays

  2000cites this paper
• Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment

  2000cites this paper
• Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.

  2000cites this paper
• Low-doses of ionising radiation induce melanoma metastases and trigger the immune system--adrenal axis feedback loop.

  1999cites this paper
• Investigation on the iodination reaction of methylene blue by liquid chromatography-mass spectrometry with ionspray ionisation.

  1999cites this paper
• Targeting Melanoma with 211 At/131I-Methylene Blue: Preclinical and Clinical Experience

  1999cites this paper
• Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.

  1998cites this paper
• Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.

  1998cites this paper
• Early detection of melanoma metastases with radioiodinated methylene blue

  1998cites this paper
• Astatine-211-labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy.

  1998cites this paper
• Microdosimetry of astatine-211 using histological images: application to bone marrow.

  1997cites this paper
• Radioiodinated methylene blue for melanoma targeting: chemical characterisation and tumour selectivity of labelled components.

  1997cites this paper
• Preparation and biological evaluation of an astatine-211 labeled biotin conjugate: biotinyl-3-[211 At]astatoanilide.

  1997cites this paper
• Targeting disseminated melanoma with radiolabelled methylene blue: Comparative bio-distribution studies in man and animals.

  1996cites this paper
• Targeted therapy using alpha emitters.

  1996cites this paper
• Radiotoxicity of systematically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: a long-term survival study with histologic analysis.

  1996cites this paper
• 211At-methylene blue for targeted radiotherapy of disseminated melanoma: microscopic analysis of tumour versus normal tissue damage.

  1996cites this paper
• [211At]methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours.

  1996cites this paper
• Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (alpha,2n)211 at reaction.

  1996cites this paper
• Auger-electron spectra of radionuclides for therapy and diagnostics.

  1996cites this paper
• Radionuclides and carrier molecules for therapy.

  1996cites this paper
• Methylene blue sensitizes E. coli cells to X-rays.

  1996cites this paper
• Radioiodinated methylene blue for diagnosing early melanoma metastases.

  1996cites this paper
• Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reaction

  1996cites this paper
• Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide.

  1995cites this paper
• Management of recurrent cutaneous melanoma.

  1994cites this paper
• Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.

  1994cites this paper
• 211At-Methylene Blue in Targeted Radiotherapy of Disseminated Melanoma

  1994cites this paper
• Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.

  1994cites this paper
• 211At-methylene blue in targeted radiotherapy of disseminated melanoma.

  1994cites this paper
• Recurrent cutaneous melanoma: a surgical perspective.

  1993cites this paper
• Photochemical interactions of methylene blue and analogues with DNA and other biological substrates.

  1993cites this paper
• In vitro and in vivo targeting of gene expression to melanoma cells.

  1993cites this paper
• 211At-labelling of polymer particles for radiotherapy : synthesis, purification and stability

  1993cites this paper
• Photochemical interactions of methylene blue and analogues with DNA and other biological substrates.

  1993cites this paper
• Progress and Prospects for Therapeutic Targeting Strategies for Disseminated Melanoma

  1992cites this paper
• Melanogenesis: a realistic target for antimelanoma therapy?

  1991cites this paper